Life Sciences & Healthcare

In life sciences, a leader answers to patients and to shareholders in the same breath.

The science is why the enterprise exists; the capital is what lets it continue. We advise on the leaders who serve both without failing either.

The ones who matter keep the mission honest while making it viable, and they rarely find it easy.

The work spans big pharma and the biotech betting a company on a single molecule, the medtech a surgeon's hand depends on, and now the longevity science reaching for more years and better ones. Each is a different business with a different clock, and the leader who fits one seldom fits the next.

Ownership changes the question. A scientist-founder's venture is led differently from a listed global platform, and an investor-backed innovator racing a clock differently again. Each wants a leader who fits not only the science but the stage the business has reached, and we settle that at the start.

We are trusted with the appointments that carry the most weight: chief executives and the scientific and clinical leaders who set direction; the heads of regulatory and quality on whom trust depends; the commercial and market-access leaders who get a therapy to the people who need it; and the boards that hold all of it to account. The work reaches biopharma and medtech, diagnostics, digital health, and integrated care.

The centres of gravity here are not the ones most assume. They sit in Europe, where the great names were built; across Asia, where much of the world's medicine is now made and increasingly discovered; and in the Nordics, whose biotech and medtech run well ahead of their size. That map, rather than the American one, is where we are strongest.

We are trusted with these when an appointment will shape not only a company's direction but the lives its work reaches, and when integrity counts for as much as the record. A partner leads it from the first meeting to the placement.